Squamous cell carcinoma of skin
RecruitingStudy of nivolumab and ipilimumab combination therapy as an alternative to surgery and radiation in patients with skin squamous cell carcinoma
Study of nivolumab and ipilimumab combination therapy as an alternative to surgery and radiation in patients with skin squamous cell carcinoma
- Disease:Squamous cell carcinoma of skin
- Substances:IpilimumabNivolumab
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Ipilimumab
- Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting











